{
  "id": 13245755,
  "title": "Parkinson's cell therapy biotech Aspen and I&I startup Bambusa file for IPOs",
  "url": "https://urgent.news/2026/10/09/parkinsons-cell-therapy-biotech-aspen-and-i-i-startup-bambusa-file",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-09T22:48:48.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/parkinsons-cell-therapy-biotech-aspen-and-ii-startup-bambusa-file-for-ipos/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A Gilead-backed cell therapy maker and an I&I biotech from BioNTech vets are looking to ride the biotech industry's IPO momentum. Aspen Neuroscience and Bambusa Therapeutics are the latest drug developers to ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}